These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15577145)

  • 1. [Treatment of the keratinizing skin disorder, psoriasis, by topical vitamin D3].
    Takahashi H; Iizuka H
    Clin Calcium; 2004 Oct; 14(10):129-32. PubMed ID: 15577145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
    Takahashi H; Ibe M; Kinouchi M; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
    J Dermatol Sci; 2003 Feb; 31(1):21-8. PubMed ID: 12615360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium effects and systemic exposure of vitamin D3 analogues after topical treatment of active vitamin D3-containing ointments in rats.
    Hosomi A; Hirabe M; Tokuda T; Nakamura H; Amano T; Okamoto T
    Eur J Pharmacol; 2016 Oct; 788():98-103. PubMed ID: 27321871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects on vitamin D3 ointment; treatment of senile warts with topical application of active forms of vitamin D3].
    Mitsuhashi Y
    Clin Calcium; 2004 Oct; 14(10):141-4. PubMed ID: 15577148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin D3 for external application--history of development and clinical application].
    Tarutani M
    Clin Calcium; 2004 Oct; 14(10):124-8. PubMed ID: 15577144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamine D analogue-based therapies for psoriasis.
    O'Neill JL; Feldman SR
    Drugs Today (Barc); 2010 May; 46(5):351-60. PubMed ID: 20517536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on vitamin D3 analogues in the treatment of psoriasis.
    van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 1998; 11(1):2-10. PubMed ID: 9603664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical vitamin D3 derivatives impair the epidermal permeability barrier in normal mouse skin.
    von Brenken S; Jensen JM; Fartasch M; Proksch E
    Dermatology; 1997; 194(2):151-6. PubMed ID: 9094464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 analogues.
    Kragballe K
    Dermatol Clin; 1995 Oct; 13(4):835-9. PubMed ID: 8785887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontiers in vitamin D; basic research and clinical application. Activated vitamin D in psoriasis].
    Okuro M; Morimoto S
    Clin Calcium; 2011 Nov; 21(11):37-42. PubMed ID: 22040819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation.
    Reichrath J; Perez A; Müller SM; Chen TC; Kerber A; Bahmer FA; Holick MF
    Acta Derm Venereol; 1997 Jul; 77(4):268-72. PubMed ID: 9228216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure.
    Adachi Y; Uchida N; Matsuo T; Horio T
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):16-8. PubMed ID: 18201352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms.
    van de Kerkhof PC
    Br J Dermatol; 1995 May; 132(5):675-82. PubMed ID: 7772470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D3 derivatives, alone or in combination with glucocorticoids, suppress streptococcal pyrogenic enterotoxin A-stimulated proliferation of peripheral blood mononuclear cells in patients with psoriasis.
    Usui K; Okubo Y; Hirano T; Tsuboi R
    J Dermatol; 2017 May; 44(5):567-572. PubMed ID: 28012189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of clinical efficacy and safety of topical tacalcitol.
    Leone G; Pacifico A
    Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New perspective of vitamin D3 ointment--pruritic skin diseases: focused on prurigo].
    Katayama I
    Clin Calcium; 2004 Oct; 14(10):133-6. PubMed ID: 15577146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion.
    Fujiyama T; Ito T; Umayahara T; Ikeya S; Tatsuno K; Funakoshi A; Hashizume H; Tokura Y
    J Allergy Clin Immunol; 2016 Aug; 138(2):517-528.e5. PubMed ID: 27315769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D3-based conjugates for topical treatment of psoriasis: synthesis, antiproliferative activity, and cutaneous penetration studies.
    Ben-Shabat S; Benisty R; Wormser U; Sintov AC
    Pharm Res; 2005 Jan; 22(1):50-7. PubMed ID: 15771229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
    Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.